Amphastar Pharmaceuticals, Inc. SEC filings AMPH

Amphastar Pharmaceuticals, Inc. has 954 filings in SEC EDGAR's recent list, going back to Feb 11, 2005. Its latest annual report, Form ARS, was filed on Apr 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Amphastar Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
144 Notice of proposed sale Nov 4, 2026 —
4 Insider transaction Sep 23, 2026 Sep 21, 2026
144 Notice of proposed sale Sep 21, 2026 —
4 Insider transaction Sep 17, 2026 Sep 16, 2026
4 Insider transaction Sep 3, 2026 Sep 2, 2026
144 Notice of proposed sale Sep 1, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
4 Insider transaction Aug 12, 2026 Aug 11, 2026
4 Insider transaction Aug 11, 2026 Aug 7, 2026
144 Notice of proposed sale Aug 11, 2026 —
144 Notice of proposed sale Aug 7, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G Ownership over 5% (passive) Jul 14, 2026 —
4 Insider transaction Jul 13, 2026 Jul 9, 2026
3 Initial insider ownership Jul 13, 2026 Jul 9, 2026
8-K Current report
Officer or director change
Jul 13, 2026 Jul 9, 2026
8-K Current report
Other events
Jul 8, 2026 Jul 2, 2026
4 Insider transaction Jun 3, 2026 Aug 19, 2024
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
4 Insider transaction Jun 3, 2026 Jun 1, 2026
8-K Current report
Shareholder vote results
Jun 3, 2026 Jun 1, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 13, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 13, 2026 —
DEF 14A Proxy statement Apr 13, 2026 Jun 1, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
4 Insider transaction Mar 17, 2026 Mar 15, 2026
8-K Current report
Other events
Mar 16, 2026 Mar 12, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
8-K Current report
Officer or director change
Mar 6, 2026 Mar 3, 2026
8-K Current report
Material agreement
Mar 6, 2026 Mar 3, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 26, 2026 Feb 26, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Jan 12, 2026 Jan 6, 2026
4 Insider transaction Dec 18, 2025 Dec 17, 2025
4 Insider transaction Dec 15, 2025 Dec 11, 2025
144 Notice of proposed sale Dec 11, 2025 —
144 Notice of proposed sale Dec 10, 2025 —
144 Notice of proposed sale Nov 28, 2025 —
4 Insider transaction Nov 25, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Nov 17, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 13, 2025 —
10-Q Quarterly report Nov 6, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 6, 2025 Nov 6, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 3, 2025 —
8-K Current report
Material agreement
Oct 24, 2025 Oct 21, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 17, 2025 —
4 Insider transaction Oct 2, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 1, 2025 —
8-K Current report
Material agreement
Sep 18, 2025 Sep 15, 2025
4 Insider transaction Sep 3, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 2, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Aug 12, 2025 Aug 8, 2025
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
4 Insider transaction Aug 4, 2025 Aug 1, 2025
144 Notice of proposed sale Aug 1, 2025 —
4 Insider transaction Jul 22, 2025 Jul 18, 2025
3 Initial insider ownership Jul 22, 2025 Jul 18, 2025
8-K Current report
Officer or director change
Jul 21, 2025 Jul 18, 2025
4 Insider transaction Jul 3, 2025 Jul 2, 2025
144 Notice of proposed sale Jul 2, 2025 —
4 Insider transaction Jun 16, 2025 Jun 13, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
4 Insider transaction Jun 4, 2025 Jun 2, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 4, 2025 Jun 2, 2025
144 Notice of proposed sale Jun 2, 2025 —
4 Insider transaction May 20, 2025 May 19, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
4 Insider transaction May 2, 2025 May 1, 2025
144 Notice of proposed sale May 1, 2025 —
ARS Annual report to shareholders Apr 14, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 14, 2025 —
DEF 14A Proxy statement Apr 14, 2025 Jun 2, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
PRE 14A Preliminary proxy statement Apr 2, 2025 Jun 2, 2025
144 Notice of proposed sale Apr 1, 2025 —
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 14, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 18, 2025 Mar 15, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 10, 2025 Mar 6, 2025
4 Insider transaction Mar 7, 2025 Mar 6, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
4 Insider transaction Mar 6, 2025 Mar 4, 2025
144 Notice of proposed sale Mar 6, 2025 —
144 Notice of proposed sale Mar 4, 2025 —
10-K Annual report Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 7, 2025 —
4 Insider transaction Dec 16, 2024 Dec 12, 2024
4 Insider transaction Dec 11, 2024 Dec 9, 2024
144 Notice of proposed sale Dec 9, 2024 —
4 Insider transaction Nov 13, 2024 Nov 12, 2024
4 Insider transaction Nov 13, 2024 Nov 12, 2024
4 Insider transaction Nov 12, 2024 Nov 11, 2024
144 Notice of proposed sale Nov 12, 2024 —
144 Notice of proposed sale Nov 12, 2024 —
4 Insider transaction Nov 8, 2024 Nov 6, 2024
4 Insider transaction Nov 8, 2024 Nov 6, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
144 Notice of proposed sale Nov 6, 2024 —
144 Notice of proposed sale Nov 6, 2024 —
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
4 Insider transaction Sep 17, 2024 Sep 13, 2024
4 Insider transaction Sep 16, 2024 Sep 13, 2024
4 Insider transaction Sep 6, 2024 Sep 5, 2024
144 Notice of proposed sale Sep 5, 2024 —
8-K Current report
Material agreement
Aug 30, 2024 Aug 28, 2024
4 Insider transaction Aug 27, 2024 Aug 26, 2024
144 Notice of proposed sale Aug 26, 2024 —
4 Insider transaction Aug 13, 2024 Aug 12, 2024
144 Notice of proposed sale Aug 12, 2024 —
10-Q Quarterly report Aug 9, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
4 Insider transaction Aug 2, 2024 Jul 31, 2024
144 Notice of proposed sale Jul 31, 2024 —
4 Insider transaction Jun 28, 2024 Jun 27, 2024
144 Notice of proposed sale Jun 27, 2024 —
4 Insider transaction Jun 11, 2024 Jun 10, 2024
4 Insider transaction Jun 11, 2024 Jun 10, 2024
144 Notice of proposed sale Jun 10, 2024 —
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 4, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
4 Insider transaction Jun 5, 2024 Jun 3, 2024
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 4, 2024 Jun 3, 2024
144 Notice of proposed sale Jun 3, 2024 —
4 Insider transaction May 21, 2024 May 19, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 8, 2024 May 8, 2024
4 Insider transaction May 2, 2024 May 1, 2024
144 Notice of proposed sale May 1, 2024 —
DEFA14A Additional proxy material Apr 19, 2024 —
ARS Annual report to shareholders Apr 12, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 12, 2024 —
DEF 14A Proxy statement Apr 12, 2024 Jun 3, 2024
4 Insider transaction Apr 2, 2024 Apr 1, 2024
144 Notice of proposed sale Apr 1, 2024 —
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 8, 2024 Mar 6, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 5, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
4 Insider transaction Mar 6, 2024 Mar 4, 2024
144 Notice of proposed sale Mar 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Mar 6, 2024 —
144 Notice of proposed sale Mar 5, 2024 —
4 Insider transaction Mar 4, 2024 Mar 1, 2024
144 Notice of proposed sale Mar 1, 2024 —
S-8 Employee stock plan registration Feb 29, 2024 —
10-K Annual report Feb 29, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 28, 2024 Feb 28, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
AMPH (Nasdaq)
Fiscal year ends
December 31
Headquarters
Rancho Cucamonga, CA
SEC filer status
Large accelerated filer
SEC CIK
1297184

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.